Skip To Main Content
Tania Chakrabarty on Muck Rack

Tania Chakrabarty

As seen in: Cell & Gene Therapy Insights
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Tania

Contact Tania, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Development & validation of a robust commercial solution for measuring residual kanamycin-resistant plasmid DNA

|
By Tania Chakrabarty
| Cell & Gene Therapy Insights Verified
As you are already a member of Immuno-Oncology Insights (also from Bioinsights), all you need to do is tick the box below. I would like to become a member of Cell & Gene Therapy
Open in Who Shared View Duplicates (2) Issue with article?

Open Insulin

|
By Maureen Muldavin, Tania Chakrabarty, David Anderson, Catherine Soneda
| experiment.com
About This Project A team of biohackers is developing the first open source protocol to produce insulin simply and economically. Our work may serve as a basis for generic production of this life-saving drug and provide a firmer foundation for continued research into improved versions of insulin. See also: New York Times Vice Magazine Popular Science Ask the Scientists Join The Discussion What is the context of this research?
Open in Who Shared Issue with article?

Open Insulin

|
By David Anderson, Yilan Shi, Maureen Muldavin, Tania Chakrabarty, Catherine Soneda
| experiment.com
There are currently about 387 million people worldwide living with diabetes. Meanwhile, as discussed by Jeremy A. Greene and Kevin R. Riggs in their March 2015 article in the New England Journal of Medicine, there is no generic insulin available on the market despite great demand in poorer communities and regions of the world. As a result, many go without insulin and suffer complications including blindness, cardiovascular disease, amputations, nerve and kidney damage, and even death.
Open in Who Shared Issue with article?
See all 3 articles